Saturday, May 21, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina

NEWS

plasma

Beijing, Sep 6 (Prensa Latina) A Chinese pharmaceutical company will begin clinical trials of a Covid-19 drug, developed from the blood plasma of patients who have recovered from that disease and vaccinated individuals, local press informed on Monday.